RNA N6-methyladenosine modifications in urological cancers: from mechanism to application

Lei Yang1, Jianming Ying2, Qian Tao3

  • 1Department of Urology, Peking University First Hospital, Institute of Urology, National Research Center for Genitourinary Oncology, Peking University, Beijing, China.

Nature Reviews. Urology
|February 12, 2024
PubMed

Insights

N6-methyladenosine (m6A) RNA modification is crucial in urological cancers. Dysregulated m6A regulators show potential as diagnostic biomarkers and therapeutic targets for kidney, bladder, and prostate cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • N6-methyladenosine (m6A) is the most prevalent mRNA modification in eukaryotes.
  • m6A plays critical roles in various cancers, including urological malignancies like renal cell carcinoma, bladder cancer, and prostate cancer.
  • m6A modification is regulated by writers, erasers, and readers, influencing post-transcriptional gene expression.

Purpose of the Study:

  • To review the current evidence on the association between m6A modification and urological cancers.
  • To describe the complex and context-dependent roles of dysregulated m6A modifications in these cancers.
  • To highlight the potential of m6A regulators as diagnostic/prognostic biomarkers and therapeutic targets.

Main Methods:

  • Literature review of studies investigating m6A modification in urological cancers.
  • Analysis of evidence linking m6A regulators to cancer development, progression, and prognosis.
  • Synthesis of information on the functional impact of m6A dysregulation.

Main Results:

  • Aberrant m6A modification is significantly associated with the development, progression, and prognosis of urological cancers.
  • Dysregulated m6A regulators exhibit complex, context-dependent effects in these malignancies.
  • Evidence suggests m6A regulators can serve as valuable biomarkers and therapeutic targets.

Conclusions:

  • m6A modification is a key player in urological cancer biology.
  • Targeting m6A regulators offers promising avenues for diagnostics and therapeutics in urological cancers.
  • Further research into m6A pathways is warranted for clinical applications.

Related Concept Videos

RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.5K
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
11.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.3K